Recensa has the personnel, the technology, and the Nrf2 expertise to bring novel topical therapies successfully to market. If you are interested in partnering with our team, please click below.


Matt Handel


Matt Handel is a life sciences entrepreneur, executive and board director who cofounded Recensa in 2016. Matt has worked closely with colleagues in industry, venture capital, banking and government, both in the U.S. and globally.

Matt began his career at Merck & Co. and then spent 11 years at Shire Pharmaceuticals in business development, business intelligence and product leadership. Matt was most recently at G&W Laboratories, Inc., where he built a new product selection process and identified business opportunities. Matt is a Board Director of PolyAurum, LLC, an oncology company.

Matt earned his M.S. from the MIT Sloan School of Management and his B.A. from Princeton University. He sits on several non-profit Boards that support human services in the Philadelphia area. In his younger days, Matt was a three-day champion on the television show Jeopardy.


OSCAR PEREZ leal, m.d.

scientific co-founder

Oscar Perez, MD, cofounded Recensa in 2016 while serving as Assistant Professor at Temple University’s School of Pharmacy. Previous to that, he received his MD in 2002 from the Universidad del Norte, Colombia, after which he completed his postdoctoral training in Biochemistry and Molecular Biology at Temple University in 2009.

Oscar had an early passion for drug discovery, and focused his research efforts on identifying novel drug targets for inflammatory diseases as well as various types of cancers. Upon seeing the potential of his research, he later pursued a Masters in Innovation and Entrepreneurship from the Fox School of Business, where he dedicated a significant portion of his project work to evolving the potential behind his four patents as they related to commercializing and fast tracking his drug development research.

Dr. Perez's novel technology is currently being used by Recensa to develop novel topical treatments for Psoriasis where antioxidant-inducing drugs will have a profound impact.




Recensa Therapeutics has a dynamic team dedicated to using research to improve the lives of patients. . We will need employees and corporate partners. If you want to join us in our goal to better the lives of psoriasis patients by working with us, please click the tab below.

Stock photo of a portfolio and two businessmen reviewing reports.jpg